Company profile for Xlife Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Xlife Sciences AG builds the bridge from research and development to health care markets. We support researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. Together with industrial partners or universities, the firm takes projects a step further after an invention. Subsequently, Xlife Sciences AG focuses on out-licensing or selling the company, often with a combination of a st...
Xlife Sciences AG builds the bridge from research and development to health care markets. We support researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. Together with industrial partners or universities, the firm takes projects a step further after an invention. Subsequently, Xlife Sciences AG focuses on out-licensing or selling the company, often with a combination of a strategic partnership. The company offers its investors direct access to the further development of innovative and future-oriented technologies at a very early stage.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Klausstrasse 19, Zürich, Zürich 8008, CH
Telephone
Telephone
+41 44 385 84 60
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-06-13/strategic-alliance-between-xlife-sciences-ag-jipyong-llc-and-jipyong-ip-to-accelerate-korean-life-s

PHARMAWEB
13 Jun 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/veraxa-biotech-merge-with-spac-voyager-164-billion-deal-2025-04-23/

REUTERS
23 Apr 2025

https://www.pharmiweb.com/press-release/2024-12-23/xlife-sciences-ag-announces-potential-acquisition-of-portfolio-company-fuse-ai-gmbh-by-pineapple-pow

PHARMAWEB
23 Dec 2024

https://www.pharmiweb.com/press-release/2024-12-16/xlife-sciences-ag-announces-the-intended-listing-of-veraxa-biotech-ag-on-the-nasdaq-stock-exchange-i

PHARMAWEB
16 Dec 2024

https://www.pharmiweb.com/press-release/2024-11-21/xlife-sciences-ag-announces-the-listing-of-fuse-ai-gmbh-on-the-london-stock-exchange-in-the-first-ha

PHARMAWEB
21 Nov 2024

https://www.pharmiweb.com/press-release/2024-05-27/xlife-sciences-ag-announces-strategic-merger-between-palleos-healthcare-gmbh-and-oct-clinical-gmbh

PHARMIWEB
27 May 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty